FGF21 ELISA
- Regulatory Status
- RUO
- Kit size
- 12 x 8
- Method
- ELISA
- Incubation time
- 1 x 18h, 2 x 30min.
- Standard range
- 31.3 - 2000 pg/mL
- Specimen / Volumes
- 100 µL serum, EDTA plasma, cell culture supernatant
- Substrate / isotope
- TMB 450nm
The FGF19 subfamily composed of FGF15/19, FGF21 and FGF23 binds the FGF receptors co-joined by α- or β-Klotho and it is characterized as a factor group which has hormonal functions. The novel system consisted of α/βKlotho and FGF19 subfamily regulates integrally metabolism of minerals, lipids, energy and amino acids. This novel regulating system involves important homeostatic mechanisms in the body such as bile acid and cholesterol metabolism in the liver (through FGF19), energy and glycolipids metabolism (through FGF21) and phosphate, calcium and vitamin D metabolism in kidney (through FGF23) in fasting state.
FGF21 is secreted in the liver and it is responsible for glucose uptake of adipocytes. FGF21 binds to a receptor unit consisting of FGFR and β-Klotho. It has been shown that treating animals with FGF21 leads to increased energy expenditure, fat utilization and lipid excretion meaning a decrease of glucose and triglyceride levels in blood.
FGF21 levels in blood correlate with many diseases like gestational diabetes mellitus, mitochondrial dysfunction in HIV infection, friedreich ataxia, coronary artery disease, carotid atherosclerosis, non-alcoholic fatty liver disease, rheumatoid arthritis, diabetic nephropathy, type2 diabetes, dyslipidemia, obesity and metabolic syndrome.
This kit measures FGF21 levels in serum, EDTA plasma and cell culture supernatants.
Separate control set available on request
Distributed by IBL International
Our Product Families
Our comprehensive immunoassay portfolio includes a number of specialty diagnostic immunoassays for endocrinology, immunology and autoimmunity, as well as for diagnosis of multiple infectious diseases. We are pioneers and market leaders in saliva diagnostics, with over 40 years of experience supplying a broad portfolio of luminescence- and ELISA-based tests, including our highly acclaimed HMGB1 and MuSK-Ab ELISAs.
And as experts in laboratory automation, we can support our customers with the protocols for open ELISA platforms, such as the Freedom EVOlyzer or Thunderbolt®.
All products are only available for sale to laboratory professionals and may not be available in all countries. Availability and regulatory status may vary across regions depending on local country-specific registration. Please always read and follow the instructions for use.
All of our assays have been designed and manufactured to meet the highest global regulatory requirements and quality standards. Tecan is certified under ISO 9001:2015, ISO 13485:2016 and is audited by a notified body according to Medical Device Single Audit Program (MDSAP).
This is who we are.
As part of the Tecan Group, we have a leading market position in diagnostics and research, with over 40 years of experience in the development, manufacture and supply of enzyme-, radiolabel- and luminescence-based immunoassays.
Our range of high-quality immunoassays is supported by a diverse portfolio of automated solutions, making us the perfect partner for you and your customers.
Happy to help.
At Tecan, we are driven to improve people’s lives and health.